Back to UBS Group AG UBS Group AG

LPCNLPCN
Showing 8 of 12 quarters

Position history for UBS Group AGUBS Group AG's holdings in LIPOCINE INC NEW

UBS Group AG holds 3,596 shares of LPCN (LIPOCINE INC NEW), worth $9,206 as of 2026-Q2. The position was increased (+2.9% shares).

Current Value

$9,206

Current Shares

3,596

Total Value Change

-$257,558

Total Shares Change

-55,817

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
3,596
+2.9%
$9,2060.0%$2.56
12
2026-Q1
Decreased
3,494
-37.6%
$27,9170.0%$8.42
0
2025-Q4
Increased
5,603
+217.3%
$44,9920.0%$6.57
22
2025-Q3
Increased
1,766
+271.8%
$5,0340.0%$2.81
17
2025-Q2
Increased
475
+138.7%
$1,5010.0%$3.29
12
2025-Q1
Increased
199
+6533.3%
$6320.0%$3.28
12
2024-Q4
Decreased
3
-100.0%
$150.0%$4.58
0
2024-Q3
Increased
59,413
+5.7%
$266,7640.0%$4.44
25

Other major holders of LPCN: VANGUARD GROUP INC, VANGUARD CAPITAL MANAGEMENT LLC, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used